Cargando…
Saccharomyces Boulardii in Helicobacter Pylori Eradication in Children: A Randomized Trial From Iran
BACKGROUND: Helicobacter pylori infects around 50% of the human population and is asymptomatic in 70% of the cases. H. pylori eradication in childhood will not only result in peptic symptoms relief, but will also prevent late-term complications such as cancer. Today, probiotics are being increasingl...
Autores principales: | Namkin, Kokab, Zardast, Mahmood, Basirinejad, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733292/ https://www.ncbi.nlm.nih.gov/pubmed/26848376 http://dx.doi.org/10.5812/ijp.3768 |
Ejemplares similares
-
The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015) -
Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial
por: Zhao, Yuchong, et al.
Publicado: (2021) -
The efficacy and safety of Saccharomyces boulardii in addition to antofloxacin-based bismuth quadruple therapy for Helicobacter pylori eradication: a single-center, prospective randomized-control study
por: He, Xiao-Jian, et al.
Publicado: (2023) -
Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial
por: Naghibzadeh, Nooshin, et al.
Publicado: (2022) -
Eradication of Helicobacter Pylori in Iran: A Review
por: Fakheri, Hafez, et al.
Publicado: (2018)